Featured Research

from universities, journals, and other organizations

Protein Strengthens Link Between Addiction And Long-Term Memory

Date:
March 27, 1997
Source:
Johns Hopkins Medical Institutions
Summary:
Johns Hopkins scientists have discovered a new protein, called Homer, that becomes active in rat brain cells during exposure to cocaine and during a lab model of long-term memory creation.


Johns Hopkins Medical Institutions' news releases are available on a PRE-EMBARGOED basis on
EurekAlert at http://www.eurekalert.org and from the Office of Communications and Public Affairs'
direct e-mail news release service. To enroll, call 410-955-4288 or send e-mail to
bpalevic@welchlink.welch.jhu.edu or 76520.560@compuserve.com.



On a POST-EMBARGOED basis find them at http://hopkins.med.jhu.edu,
http://infonet.welch.jhu.edu/news/news_releases, Newswise at http://www.ari.net/newswise or on
CompuServe in the SciNews-MedNews library of the Journalism Forum under file extension ".JHM",
Quadnet at http://www.quad-net.com or ScienceDaily at http://www.sciencedaily.com. ************************************************


PROTEIN STRENGTHENS LINK BETWEEN ADDICTION AND LONG-TERM MEMORY


Johns Hopkins scientists have discovered a new protein, called Homer, that
becomes active in rat brain cells during exposure to cocaine and during a lab model of
long-term memory creation.

"Homer is one of the first links between drug addiction and long-term memory
that directly acts on nerve cells' message-receiving structures," says Paul Worley, M.D.,
an associate professor of neuroscience and neurology. "As such, it could be an important
step toward understanding the connections between addiction and memory, and toward
developing new treatments for addiction."

In a study funded by the National Institute on Drug Abuse and published in
Nature, he found Homer by exposing rat brain cells to cocaine and to a lab model of
memory used by neuroscientists.

"We call the protein Homer because it homes in' on critical areas where
messages are being passed between nerve cells," says Worley.

In the memory model, researchers stimulate a nerve cell with an electric current
and measure the resulting transmission of information between neurons.

If the current is given often and rapidly enough over a period of time, the nerve
cell activates a number of genes and makes a number of complex changes that allow it to
communicate more quickly and more effectively.

Neuroscientists think the brain may use this and other similar processes to
enhance or weaken connections between nerve cells, and that this may be a key to the
creation of memory.

Worley's group found that nerve cells increased their Homer production levels
nearly 50 times within minutes of their activation, and that Homer binds to a message
receptor on the surface of excitatory nerve cells, the metabotropic glutamate receptor.

"We think with further research we may find that Homer allows these receptors to
stay open longer or to open up more easily," says Worley. "We believe it does something
to enhance message reception, and will provide fundamental insights into how the brain
maintains long-term memories or becomes addicted to drugs like cocaine."

As scientists learn more about Homer's effects, and its links to other changes in
the nerve cell, new targets for drug treatments may become available.

Under an agreement between Lynx Therapeutics, a California Company, and the
Johns Hopkins University, Lynx has right of first refusal for licensing Homer. Worley
serves as a consultant to Lynx, owns stock in Lynx, and has received Lynx stock options,
which are subject to certain restrictions under University policy. This arrangement is
being managed by the University in accordance with its conflict of interest policies.

Other authors on the Nature paper were Paul Brakeman, Anthony Lanahan,
Richard O'Brien, Katherine Roche, Carol Barnes and Richard Huganir.

--JHMI--

Media contact: Michael Purdy, (410) 955-8725

E-mail: mpurdy@welchlink.welch.jhu.edu



Story Source:

The above story is based on materials provided by Johns Hopkins Medical Institutions. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Medical Institutions. "Protein Strengthens Link Between Addiction And Long-Term Memory." ScienceDaily. ScienceDaily, 27 March 1997. <www.sciencedaily.com/releases/1997/03/970327122338.htm>.
Johns Hopkins Medical Institutions. (1997, March 27). Protein Strengthens Link Between Addiction And Long-Term Memory. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/1997/03/970327122338.htm
Johns Hopkins Medical Institutions. "Protein Strengthens Link Between Addiction And Long-Term Memory." ScienceDaily. www.sciencedaily.com/releases/1997/03/970327122338.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins